Panagora Asset Management’s Statera Biopharma STAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
– Sell
-10,427
Closed -$42K – 2423
2017
Q4
$42K Buy
+10,427
New +$31.7K ﹤0.01% 2081

Other funds holding STAB

Panagora Asset Management's STAB Position: Q1 2018 in Review

Panagora Asset Management sold out of Statera Biopharma (STAB) in Q1 2018, closing a stake of 10,427 shares — an estimated $42K sold.

Panagora Asset Management first reported a position in STAB in Q4 2017 and held it in 1 quarter. The position peaked at $42K in Q4 2017. 16 funds tracked by Wall St. Rank hold STAB as of Q1 2018.

  • Panagora Asset Management reported no remaining Statera Biopharma position as of Q1 2018 after selling out during the quarter.
  • Panagora Asset Management sold 10,427 Statera Biopharma shares in Q1 2018, an estimated $42K.
  • Panagora Asset Management first reported a position in Statera Biopharma in Q4 2017 and held it in 1 quarter.
  • Panagora Asset Management's Statera Biopharma position peaked at $42K in Q4 2017.
  • 16 funds tracked by Wall St. Rank held Statera Biopharma as of Q1 2018.

Based on Panagora Asset Management's 13F filing for Q1 2018, filed 15 May 2018.